A M Maffione1, S Chondrogiannis2, C Capirci2, F Galeotti3, A Fornasiero4, G Crepaldi5, G Grassetto6, L Rampin6, M C Marzola6, D Rubello6. 1. Department of Nuclear Medicine, PET Unit, Nuclear Medicine & PET/CT Centre, Santa Maria della Misericordia Hospital, Viale Tre Martiri, 140, 45100 Rovigo, Italy. Electronic address: maffione.marghe@libero.it. 2. Radiotherapy Unit, Santa Maria della Misericordia Hospital, Rovigo, Italy. 3. Surgical Oncology Unit, Santa Maria della Misericordia Hospital, Rovigo, Italy. 4. Medical Oncology Unit, Sant'Antonio Hospital, Padova, Italy. 5. Medical Oncology Unit, Santa Maria della Misericordia Hospital, Rovigo, Italy. 6. Department of Nuclear Medicine, PET Unit, Nuclear Medicine & PET/CT Centre, Santa Maria della Misericordia Hospital, Viale Tre Martiri, 140, 45100 Rovigo, Italy.
Abstract
AIM: To assess the predictive value of fluorine-18-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) in early assessing response during neo-adjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer. MATERIALS AND METHODS: A systematic review was performed by search of MEDLINE Library for the following terms: "rectal carcinoma OR rectal cancer", "predictive OR prediction OR response assessment OR response OR assessment", "early OR ad interim", "therapy", "FDG OR (18)F-FDG", "PET OR PET/CT". Articles performed by the use of stand-alone PET scanners were excluded. RESULTS: 10 studies met the inclusion criteria, including 302 patients. PET/CT demonstrated a good early predictive value in the global cohort (mean sensitivity = 79%; mean specificity = 78%). SUV and its percentage decrease (response index = RI) were calculated in all studies. A higher accuracy was demonstrated for RI (mean sensitivity = 82%; pooled specificity = 85%) with a mean cut-off of 42%. The mean time point to perform PET scan during CRT resulted to be at 1.85 weeks. Some PET parameters resulted to be both predictive and not statistical predictive of response, maybe due to the small population and few studies bias. CONCLUSION: PET showed high accuracy in early prediction response during preoperative CRT, increased with the use of RI as parameter. In the era of tailored treatment, the precocious assessment of non-responder patients allows modification of the subsequent strategy especially the timing and the type of surgical approach.
AIM: To assess the predictive value of fluorine-18-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) in early assessing response during neo-adjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer. MATERIALS AND METHODS: A systematic review was performed by search of MEDLINE Library for the following terms: "rectal carcinoma OR rectal cancer", "predictive OR prediction OR response assessment OR response OR assessment", "early OR ad interim", "therapy", "FDG OR (18)F-FDG", "PET OR PET/CT". Articles performed by the use of stand-alone PET scanners were excluded. RESULTS: 10 studies met the inclusion criteria, including 302 patients. PET/CT demonstrated a good early predictive value in the global cohort (mean sensitivity = 79%; mean specificity = 78%). SUV and its percentage decrease (response index = RI) were calculated in all studies. A higher accuracy was demonstrated for RI (mean sensitivity = 82%; pooled specificity = 85%) with a mean cut-off of 42%. The mean time point to perform PET scan during CRT resulted to be at 1.85 weeks. Some PET parameters resulted to be both predictive and not statistical predictive of response, maybe due to the small population and few studies bias. CONCLUSION: PET showed high accuracy in early prediction response during preoperative CRT, increased with the use of RI as parameter. In the era of tailored treatment, the precocious assessment of non-responder patients allows modification of the subsequent strategy especially the timing and the type of surgical approach.
Authors: Niels W Schurink; Simon R van Kranen; Maaike Berbee; Wouter van Elmpt; Frans C H Bakers; Sander Roberti; Joost J M van Griethuysen; Lisa A Min; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts Journal: Eur Radiol Date: 2021-02-10 Impact factor: 5.315
Authors: Antonio Avallone; Luigi Aloj; Biagio Pecori; Corradina Caracò; Alfonso De Stefano; Fabiana Tatangelo; Lucrezia Silvestro; Vincenza Granata; Francesco Bianco; Carmela Romano; Francesca Di Gennaro; Alfredo Budillon; Antonella Petrillo; Paolo Muto; Gerardo Botti; Paolo Delrio; Secondo Lastoria Journal: J Nucl Med Date: 2019-03-15 Impact factor: 10.057
Authors: Anne Katrin Berger; Stephan Lücke; Ulrich Abel; Georg Martin Haag; Carsten Grüllich; Annika Stange; Mareike Dietrich; Leonidas Apostolidis; Angelika Freitag; Claudia Trierweiler; Carl von Gall; Jennifer Ose; Frederik Giesel; Tim Frederik Weber; Florian Lordick; Uwe Haberkorn; Dirk Jäger Journal: Br J Cancer Date: 2018-07-02 Impact factor: 7.640